(by Luke Yamaguchi | Children’s Health Defense) – The U.S. Food and Drug Administration (FDA) on Oct. 29, 2021, granted Emergency Use Authorization (EUA) of Pfizer’s COVID-19 vaccine for children 5 to 11 years of age. The Centers for Disease Control and Prevention (CDC) went on to recommend Pfizer’s COVID-19 vaccine for 28 million American children 5 to 11 years of age on Nov. 2, 2021. This week, Pfizer asked the FDA to authorize the use of a two-dose vaccine in children 6 months to 4 years old. Data on a third shot would be submitted to regulators once they became […]

This post was originally published on this site